Literature DB >> 26534767

The use of facial modeling and analysis to objectively quantify facial redness.

Negar Foolad1, Neha Prakash1, Vivian Y Shi1, Faranak Kamangar1, Qinlu Wang2, Chin-Shang Li3, Raja K Sivamani1.   

Abstract

BACKGROUND: The reproducible evaluation of facial redness is critical to the assessment of erythematotelangiectatic rosacea. Assessments have typically focused on the use of photography with the use of semi-quantitative grading scales based on evaluator rating. However, few studies have utilized computer-based algorithms to evaluate facial redness. AIM: The purpose of this clinical study was to assess whether there is correlation between clinical grading of facial redness to the assessment of a quantitative computer-based facial modeling and measurement.
MATERIAL AND METHODS: In this prospective study, a set of high-resolution facial photographs and cross-polarized subsurface photographs for erythema detection were obtained for 31 study participants. A computer algorithm was then utilized to detect and quantify facial redness in the photographs and compare this to semi-quantitative evaluator-based grading for facial redness.
RESULTS: There was a strong correlation between computer-based cross-polarized subsurface erythema quantification and clinical grading for redness intensity (Clinical Erythema Assessment), redness distribution, and overall redness severity (Modified Clinical Erythema Assessment).
CONCLUSION: Overall, facial redness measurements by facial imaging and computer analysis correlated well to clinical grading scales for both redness intensity and distribution. Future studies should incorporate facial modeling and analysis tools for assessments in clinical studies to introduce greater objectivity and quantitative analysis in facial erythema-based analyses.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  erythema; facial grading scale; imaging; photography; redness; rosacea

Mesh:

Year:  2015        PMID: 26534767      PMCID: PMC4777688          DOI: 10.1111/jocd.12191

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  10 in total

1.  Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea.

Authors:  Jonathan Wilkin; Mark Dahl; Michael Detmar; Lynn Drake; Alvan Feinstein; Richard Odom; Frank Powell
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

2.  Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea.

Authors:  K Benkali; M Leoni; F Rony; R Bouer; A Fernando; M Graeber; N Wagner
Journal:  Br J Dermatol       Date:  2014-07-16       Impact factor: 9.302

3.  Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Authors:  J Fowler; M Jarratt; A Moore; K Meadows; A Pollack; M Steinhoff; Y Liu; M Leoni
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

Review 4.  Rosacea. Pathophysiology and treatment.

Authors:  J K Wilkin
Journal:  Arch Dermatol       Date:  1994-03

5.  Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.

Authors:  Angela Moore; Steven Kempers; George Murakawa; Jonathan Weiss; Amanda Tauscher; Leonard Swinyer; Hong Liu; Matthew Leoni
Journal:  J Drugs Dermatol       Date:  2014-01       Impact factor: 2.114

6.  Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.

Authors:  Joseph Fowler; Mark Jackson; Angela Moore; Michael Jarratt; Terry Jones; Kappa Meadows; Martin Steinhoff; Diane Rudisill; Matthew Leoni
Journal:  J Drugs Dermatol       Date:  2013-06-01       Impact factor: 2.114

7.  The association of the sebum excretion rate with melasma, erythematotelangiectatic rosacea, and rhytides.

Authors:  Negar Foolad; Vivian Y Shi; Neha Prakash; Faranak Kamangar; Raja K Sivamani
Journal:  Dermatol Online J       Date:  2015-06-16

8.  Erythema dose--a novel global objective index for facial erythema by computer-aided image analysis.

Authors:  Jae Woo Choi; Soon Hyo Kwon; Seong Moon Jo; Sang Woong Youn
Journal:  Skin Res Technol       Date:  2013-05-25       Impact factor: 2.365

9.  Reliability of Clinician Erythema Assessment grading scale.

Authors:  Jerry Tan; Hong Liu; James J Leyden; Matthew J Leoni
Journal:  J Am Acad Dermatol       Date:  2014-07-04       Impact factor: 11.527

10.  Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.

Authors:  J Mark Jackson; Joseph Fowler; Angela Moore; Michael Jarratt; Terry Jones; Kappa Meadows; Martin Steinhoff; Diane Rudisill; Matthew Leoni
Journal:  J Drugs Dermatol       Date:  2014-06       Impact factor: 2.114

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.